Allogeneic Adipose Tissue Extract in Wound Treatment and Scar Maturation

Exclusion Criteria

• •Known allergy to any of the preparation used in the study (Tience)
• •Systemic cancer (does not include carcinoma in situ of the cervix or local skin cancers such as basiloma)
• •Pregnancy or nursing
• •Those who withhold consent
• •Active infection on the receptor site, donor site or sepsis
• •Any other serious disease likely to compromise the outcome of the trial, such as critical renal disease (creatinine greater than 300 mmol/l)
• •Those living at such a distance from the clinic as would make frequent assessment visits inappropriately expensive and/or impractical.
• •Those with conditions, which tend to limit a patient´s ability or willingness to restrict activities or comply with the instructions during the treatment and follow-up period.